ERBB2 and breast cancer: For example, tumor staging, hormone receptors, HER-2, chemotherapeutic and endocrine therapy drugs, Ki-67, and molecular typing have been shown to be related to breast cancer prognosis in some reports52–55, but our research has failed to confirm that these factors are related to bpCR or independent predictors of bpCR.